Meeting Coverage


A Joint Meeting of IDSA, SHEA, HIVMA, PIDS, and SIDP

Vaccine Candidates for RSV Ward Off Severe Illness in Older Adults

Trials show upwards of 85% protection against more severe cases of respiratory syncytial virus

IDWeek over a photo of the Walter E. Washington Convention Center in Washington, DC

Latest IDWeek Meeting Coverage

Start HIV Antiretroviral Therapy ASAP, Experts Urge

Higher risk of death, serious health issues with delayed therapy, data from START trial suggest

October 25, 2022
Anti-Inflammatory Agents May Have Role in COVID-19 Pneumonia

Infliximab and abatacept showed trends for improved outcomes in ACTIV-1 IM trial

October 25, 2022
A Once-Rejected Antibiotic Equals Standard for Complicated Staph Infections

Will non-inferiority data offer a second chance for ceftobiprole at FDA?

October 24, 2022
Fluticasone Delivery System Reduced Exacerbations of Chronic Rhinosinusitis

Results from two randomized trials show the device also reduced need for antibiotics

October 24, 2022
Sabizabulin Benefit in Hospitalized COVID Seen Early in Disease Course

Fewer deaths with microtubule disruptor for patients only needing oxygen via mask or nasal prongs

October 24, 2022
Novel Siderophore Cephalosporin Nets Promising Results in Tough-to-Treat CRAB

PROVE offers real-world data in carbapenem-resistant Acinetobacter baumannii

October 23, 2022
Extra Hep B Vaccine Dose Exceeds Expectations for People With HIV

Seroprotection seen in 100% of participants after three doses of Heplisav-B vaccine

October 23, 2022
Ivermectin: Still on a Losing Streak as COVID-19 Treatment

ACTIV-6 trial shows no time-to-recovery benefit with anti-parasitic in mild-to-moderate disease

October 22, 2022
Cutting Unneeded Urine Cultures a Good First Step to Less Antibiotic Use

Hospital consortium reports good results with diagnostic stewardship

October 21, 2022
Oral Microbiome Therapy for Recurrent C. Diff Mostly Holds Up at 6 Months

Half as many patients receiving SER-109 experienced recurrences versus placebo group

October 21, 2022
Engaging in Healthcare May Close Longevity Gap Between Black and White Men With HIV

Starting with HIV testing, men who have sex with men could see gains in life expectancy

October 21, 2022
U.S. Chickenpox Vaccine Program Led to Near Elimination of the Virus

Cases decreased by 99% in people under 20 after implementation of the two-dose vaccine

October 20, 2022
COVID Prevention Tx Safe, Shows Efficacy in High-Risk Groups

But numbers small, and treatment still needs to find its "niche"

October 3, 2021
Vaccine Could Be Shot in the Arm Against RSV in Older Adults

CYPRESS proof-of-concept study shows high efficacy against acute illness

October 3, 2021